11/21/2022 Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference 11/09/2022 Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update 09/19/2022 Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares 09/14/2022 Third Harmonic Bio Announces Pricing of Upsized Initial Public Offering 08/09/2022 Third Harmonic Bio Appoints Thomas M. Soloway to its Board of Directors 06/28/2022 Julie Person Joins Third Harmonic Bio as Chief Administrative Officer 06/06/2022 Third Harmonic Bio Appoints Edward R. Conner, M.D., as Chief Medical Officer 04/06/2022 Third Harmonic Bio Strengthens Management Team with Addition of Adrian S. Ray, Ph.D., as Chief Scientific Officer 03/09/2022 Third Harmonic Bio Appoints Robert Ho as Chief Financial Officer 02/16/2022 Third Harmonic Bio Launches to Advance the Next Wave of Medicine for Allergy and Inflammation
11/21/2022 Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference
11/09/2022 Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update
09/19/2022 Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
04/06/2022 Third Harmonic Bio Strengthens Management Team with Addition of Adrian S. Ray, Ph.D., as Chief Scientific Officer
02/16/2022 Third Harmonic Bio Launches to Advance the Next Wave of Medicine for Allergy and Inflammation
